We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 70

Does requesting and receiving approval for a pharmaceutical create a threat of patent infringement? A German perspective

  • Bird & Bird
  • -
  • Germany
  • -
  • February 28 2008

Under German law, neither the application for a marketing approval nor obtaining it constitutes a ‘use’ act under Section 9 German Patent Act

Federal Supreme Court of Germany decides on second medical use claims that relate to dosage recommendations

  • Bird & Bird
  • -
  • Germany
  • -
  • May 29 2007

In the decision Carvedilol II (file X ZR 23601), the Federal Supreme Court had to deal with the validity of the German part of a European patent that was defended with a main claim, the essential part of which reads as follows: “Use of Carvedilol for the manufacture of a medicament , wherein the medicament is administered in an initial dose of 3.125 mg , daily for a period of 7- 28 days .”

The liberalization of the German health care service sector

  • McDermott Will & Emery
  • -
  • Germany
  • -
  • June 7 2007

The introduction of the medical ambulatory service center has changed Germany’s health care industry in ways not seen since 2003

Transfer of patient data for invoicing purposes is unlawful

  • Hunton & Williams LLP
  • -
  • Germany
  • -
  • February 6 2009

On December 10, 2008, the German Federal Social Court (Bundessozialgericht: Az.: B 6 KA 3707 R) issued a ground-breaking decision in the health insurance sector

Ownership and operation of pharmacies can be restricted to pharmacists alone

  • McDermott Will & Emery
  • -
  • Austria, European Union, Germany
  • -
  • May 22 2009

In two recent cases, Commission v Italy and Apothekerkammer des Saarlandes and Others, the European Court of Justice (ECJ) found that the Italian and German legislation providing that only pharmacists may own and operate a pharmacy, is justified by the objective of ensuring that the provision of medicinal products to the public is reliable and of good quality

FCO prohibits hospitals merger

  • Hogan Lovells
  • -
  • Germany
  • -
  • April 1 2007

For the first time, the German Federal Cartel Office (FCO) has prohibited a merger between two public hospitals

German Federal Cartel Office imposes fine against Rossmann for below-cost selling

  • Bird & Bird
  • -
  • Germany
  • -
  • March 26 2007

The German Federal Cartel Office (FCO) has imposed a fine of 300,000 against Rossmann

Deregulation of the German health care service sector investors wanted

  • McDermott Will & Emery
  • -
  • Germany
  • -
  • April 10 2007

On 1 January 2007, the Panel Physicians Amendment Act (Vertragsarztrechtsänderungsgesetz or VÄndG) entered into force in Germany

The relationship between doctors and the commercial health care industry in Germany

  • McDermott Will & Emery
  • -
  • Germany
  • -
  • April 29 2008

The scientific and medical communities overlap, and cooperative medical research is constantly growing in size and importance

Dispute between the Federal Ministry of Health and the Federal Cartel Office over privatisation of hospitals

  • Bird & Bird
  • -
  • Germany
  • -
  • October 30 2007

The Federal Cartel Office has approved the acquisition of the psychiatric clinic Wunstorf from the federal state of Lower Saxony by the Klinikum Region Hannover GmbH only after imposing conditions